Ladanyi M - Search Results

1

Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.

Giraldo NA, Drill E, Satravada BA, Dika IE, Brannon AR, Dermawan J, Mohanty A, Ozcan K, Chakravarty D, Benayed R, Vakiani E, Abou-Alfa GK, Kundra R, Schultz N, Li BT, Berger MF, Harding JJ, Ladanyi M, O'Reilly EM, Jarnagin W, Vanderbilt C, Basturk O, Arcila ME. Giraldo NA, et al. Among authors: ladanyi m. Clin Cancer Res. 2022 Dec 15;28(24):5359-5367. doi: 10.1158/1078-0432.CCR-22-1954. Clin Cancer Res. 2022. PMID: 36228155 Free PMC article.

2

Mechanisms of methotrexate resistance in osteosarcoma.

Guo W, Healey JH, Meyers PA, Ladanyi M, Huvos AG, Bertino JR, Gorlick R. Guo W, et al. Among authors: ladanyi m. Clin Cancer Res. 1999 Mar;5(3):621-7. Clin Cancer Res. 1999. PMID: 10100715

3

Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.

Antonescu CR, Elahi A, Healey JH, Brennan MF, Lui MY, Lewis J, Jhanwar SC, Woodruff JM, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2000 Jul;6(7):2788-93. Clin Cancer Res. 2000. PMID: 10914725

4

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2001 Dec;7(12):3977-87. Clin Cancer Res. 2001. PMID: 11751490

5

Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.

Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, Jarnagin W, Ladanyi M, Klimstra DS. Tickoo SK, et al. Among authors: ladanyi m. Am J Surg Pathol. 2002 Aug;26(8):989-97. doi: 10.1097/00000478-200208000-00003. Am J Surg Pathol. 2002. PMID: 12170085

6

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Illei PB, et al. Among authors: ladanyi m. Clin Cancer Res. 2003 Jun;9(6):2108-13. Clin Cancer Res. 2003. PMID: 12796375

7

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.

Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, DeMatteo RP, Besmer P. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2003 Aug 15;9(9):3329-37. Clin Cancer Res. 2003. PMID: 12960119

8

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B. Gorlick R, et al. Among authors: ladanyi m. Clin Cancer Res. 2003 Nov 15;9(15):5442-53. Clin Cancer Res. 2003. PMID: 14654523 Review.

9

Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.

Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Barbashina V, et al. Among authors: ladanyi m. Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179

10

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.

Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA. Riely GJ, et al. Among authors: ladanyi m. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):839-44. doi: 10.1158/1078-0432.CCR-05-1846. Clin Cancer Res. 2006. PMID: 16467097 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

736 results

Search Page